Sun Pharmaceutical Industries Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

239.93

239.93

239.93

239.93

239.93

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

23,508.43

24,348.02

24,800.23

24,156.29

22,603.68

Loan funds

Secured loans

7,592.67

4,868.71

6,485.54

5,744.96

5,850.55

Unsecured loans

-

-

-

-

-

Total

31,341.03

29,456.66

31,525.70

30,141.18

28,694.16

Uses of funds

Fixed assets

Gross block

12,491.88

12,991.59

8,025.93

7,516.61

6,790.24

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

3,780.21

3,278.81

2,781.57

2,287.87

1,811.82

Net block

8,711.67

9,712.78

5,244.36

5,228.74

4,978.42

Capital work-in-progress

852.91

828.64

762.79

596.61

642.54

Investments

12,616.40

15,548.87

16,998.68

17,361.72

17,904.11

Net current assets

Current assets, loans & advances

18,806.51

14,675.19

15,993.00

15,223.26

14,189.06

Less : current liabilities & provisions

9,646.46

11,308.82

7,473.13

8,269.15

9,019.97

Total net current assets

9,160.05

3,366.37

8,519.87

6,954.11

5,169.09

Miscellaneous expenses not written

-

-

-

-

-

Total

31,341.03

29,456.66

31,525.70

30,141.18

28,694.16

Notes:

Book value of unquoted investments

200.26

193.04

31.55

392.75

17,836.03

Market value of quoted investments

-

-

9.02

8.16

139.67

Contingent liabilities

4,309.60

3,811.82

3,564.25

3,863.62

5,549.82

Number of equity sharesoutstanding (Lacs)

23993.35

23993.35

23993.35

23993.35

23993.35